Stay updated on MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.

Latest updates to the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now displays revision label v3.3.2 and the previous v3.2.0 label is removed.SummaryDifference0.0%

- Check28 days agoChange DetectedThe notice about government funding and data currency was removed from the page. No new content was added.SummaryDifference0.3%

- Check49 days agoChange DetectedThe Study Details page shows only minor formatting adjustments with no changes to core study content, including eligibility criteria, outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0) while removing the old version tag (v3.1.0).SummaryDifference1%

- Check78 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.0%

- Check92 days agoChange DetectedUpdated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No core content changes are evident.SummaryDifference0.1%

Stay in the know with updates to MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.